Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03570034Unknown

Obalon Balloon System Post-Approval Study

Role: lead

NCT04095481Unknown

Obalon Navigation/Touch System Post-Approval Study

Role: lead

NCT01444274Completed

Pilot Study to Evaluate A Novel Gastric Space Occupying Device

Role: lead

NCT03688256Completed

Obalon US Commercial Registry

Role: collaborator

NCT02235870Not ApplicableCompleted

Obalon Balloon System Pivotal IDE (SMART) Trial

Role: lead

NCT01718886Completed

European Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss

Role: lead

NCT01288456Completed

Study to Evaluate Novel Gastric Space Occupying Device

Role: lead

All 7 trials loaded